Thank you, Matthias. I am excited to be working with the entire Faraday Future team. I would like to begin by providing a financial overview, followed by a discussion on our funding effort, cost-cutting strategy and our focus on ensuring that all the SEC filings are up-to-date as well as our plans in place to address weaknesses in internal controls over financial reporting. First, I would like to summarize our financial results for 2022. Faraday Future reported an operating loss of $451 million for the full year 2022 as compared to operating loss of $354 million for the full year 2021. Operating expenses for Q4 2022 were $84 million compared to $121 million for Q4 2021. The overall increase in operating expenses for the year was mainly due to the increase in research and development expenses. The decrease in operating expenses for Q4 2022 in comparison to Q4 2021 are mainly due to timing as the significant research and development expenses were incurred in the first 9 months of the year. Net loss increased to $552 million for the full year in 2022 as compared to $517 million for the full year in 2021. The increase is mainly due to the increase in research and development expenses and the non-cash mark-to-market changes of certain notes payable and warrant liabilities in 2022 compared to a one-time loss on conversion of certain notes payables in connection with the closing of the business combination in 2021. Net loss for Q4 2022 was $154 million compared to $84 million for Q4 2021. The increase is mainly due to the increase in non-cash changes in fair value measurement of certain notes payable and warrant liabilities in 2022 and again of settlement on certain notes payables compared to a one-time gain on forgiveness of company’s payroll protection loan during Q4 2021. Turning to our balance sheet, total assets on December 31, 2022 were $510 million compared to $907 million of total assets as of December 31, 2021. Total liabilities were $328 million versus $340 million on December 31, 2021. Since the inception, the company has incurred cumulative losses from operations and negative cash flows from operating activities and the company’s cumulative deficit was approximately $3.5 billion as of December 31, 2022. Net cash used in operating activities for 2022 was $383 million compared to $340 million in 2021. Capital expenditures were $123 million for the full year 2022 compared to $96 million for the full year 2021. Net cash used by financing activities for the full year 2022 was $7 million compared to net cash provided by financing activities of $967 million for the full year in 2021. Cash as of December 31, 2022 was $19 million, including restricted cash of $2 million. The decrease in cash from December 31, 2021 to December 31, 2022 was mainly due to our significant research and development spend and the equipment purchases. Research and development accounted for 69% of total operating expenses in 2022. As of March 3, 2023, our cash position was $38 million, including restricted cash of $2 million. Our remaining cash on hand together with expected funding to be received in March and April is expected to provide us sufficient funding to produce our FF 91 Futurist product and get into the hands of customers. Now, I would like to provide a funding update. On December 15 of last year, we announced that we expect to start production of a FF 91 Futurist at the end of March 2023 subject to timely availability of $150 million to $170 million of additional funding and timely stockholder approval over authorized share increase. Since then, we have been diligently working towards that goal. On February 5, we announced that we secured $135 million in new financing commitments, pending FF’s stockholder vote to increase the authorized shares outstanding and approval of the financing and certain other closing conditions. At the February 28 Special Meeting of Stockholders, we received sufficient votes that were in favor of the increase in authorized shares. Additionally, we scheduled another Special Meeting of Stockholders on March 30, 2023 to vote on approval of this transaction as it exceeds 99% of shares outstanding. You should have received voting instructions by now. Please vote now to approve the $135 million in new financing commitments. If you have any questions with regards to voting, please refer to our voting guide at ff.com/vote. Please see the definitive proxy statement that the company filed with SEC for more information. Since December 15, 2022, we have received $112 million gross funding and secured $10 million scheduled to be received in Q1 2023. $55 million is scheduled to be funded within 5 business days of effective registration statement for shares underlining the secured convertible notes and the stockholders approval of the issuance of shares at the upcoming Special Meeting of Stockholders, which we just spoke about as well as certain other conditions. We also expect that we will receive additional $9 million from our existing investors by the end of March, which will be funded at investors’ options. Additionally, we have entered into a standby equity purchase agreement with Yorkville Advisors, which allows the company to draw funds in exchange for share issuances for up to $350 million at the company’s discretion. We will be very strategic and careful in using this facility in a manner most beneficial to stockholder value. Access to the full amount of this equity credit line is subject to certain conditions and shared press threshold is being met. Subject to certain conditions, $20 million of additional capital has been committed by one of our current investors and some of our existing investors have the right to commit up to $160 million of additional funds. It is always our plan and expectation that we should raise additional funds to move beyond the initial launch of FF 91 Futurist. We have just begun a $50 million raise to have better liquidity to support our production ramp and have already received indications of interest from investors for nearly the full amount. We would like to offer this investment opportunity to all existing stockholders that are accredited investors to consider. We will send out an investor letter shortly after this earnings call. For those current accredited investors stockholders with interest, please e-mail us at
[email protected]. We will continue to explore various debt and equity financing possibilities and we believe that after FF 91 Futurist delivery and as companies start to generate revenue we will have better access to a lower cost of capital. Finally, since I joined the company, we have implemented several cost-cutting initiatives that have enabled us to focus on our budget on core items that are essential to delivering the FF Futurist and maintain strong relationships with key suppliers. Also, I am happy to say that our team has kept our SEC filings up to date since Q1 2022 and we will expect it will continue to stay current. Additionally, I have worked with the team to evolve business and system processes and we are implementing internal controls to strengthen our corporate governance as well as financial reporting. We have recently hired several key accounting positions as well as Compliance Officer, who will also serve as our Deputy Legal Counsel. We are also engaging a third-party consulting firm to help us build our internal audit function. With that, I’ll hand it back to XF.